{
    "2018-01-09": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Novo Nordisk Confirms Bid for Ablynx But Faces Rejection",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Ablynx",
                        "Bid",
                        "Rejection"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Ozempic® approved in Canada for the treatment of adults with type 2 diabetes",
                "features": {
                    "keywords": [
                        "Ozempic",
                        "approved",
                        "Canada",
                        "type 2 diabetes"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Belgium’s Ablynx Rejects Novo Nordisk Bid",
                "features": {
                    "keywords": [
                        "Belgium",
                        "Ablynx",
                        "Rejects",
                        "Novo Nordisk",
                        "Bid"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}